brian stansky

Brian Stansky is the Director of FastForward, Johns Hopkins’ accelerator for the advancement and commercialization of innovations. Prior to joining Johns Hopkins, Brian was a Managing Director at Integral Capital Partners where he invested in late-stage venture and public equity securities of companies in the life sciences industries. Prior to joining Integral, he was a partner at ABACUS Investments LLC, a hedge fund specializing in the technology, media, and telecommunications industries and spent ten years at T. Rowe Price Associates in various research and portfolio management positions including portfolio manager of the T. Rowe Price Media & Telecommunications and Health Sciences funds. Brian also served as a FastForward Mentor-in-Residence prior to joining the JHTV staff.

Brian graduated, summa cum laude, with a B.S. degree in Accounting from Boston College and has an M.S. in Finance and Applied Economics from the Sloan School of Management at M.I.T. He is a CFA Charterholder.

Irene Gonzalez, phd

Irene Gonzalez, PhD is the President and CEO, NovoDux, a company developing the next generation of drugs for several human diseases. Dr. Gonzalez is a senior executive, entrepreneur, and inventor with more than 22 years experience in the business, management, and execution of numerous life science projects, contracts, and product development in the academic, government, and private sectors. Dr. Gonzalez has held senior executive and leadership positions in the biotech and pharmaceutical industries. She was the founder and CEO of Valens Therapeutics, Senior Vice President of Alseres Pharmaceuticals; Vice President of Boston Life Sciences; Scientific Review Officer at the NIH-NIAID; Director of the Molecular Biology Division of Boston Biomedica; Director of Genetic Engineering at Biotrax Inc; Assistant Professor and Tenured Associate Professor at the University of Mexico; Research Scientist and Post-Doctoral fellow in the Department of Biology of Johns Hopkins University. Dr. Gonzalez has been the recipient of numerous NIH-funded research grants and contracts, and has been serving for more than 20 years on the Editorial Board of several scientific journals of the American Society for Microbiology and the European and Japanese Society for Marine Biotechnology. Dr. Gonzalez has published many peer-reviewed scientific articles, book chapters, and abstracts. She also has extensive experience in technology evaluation, is a speaker on entrepreneurship, and has mentored many entrepreneurs and startup companies. Dr. Gonzalez holds BS and MS degrees from the University of Mexico, and a joint PhD degree with Johns Hopkins University. She owns several patents as a sole inventor issued by the USPTO.


Cathy Becker has worked as an early stage sales consultant for a variety of healthcare startups, from a pediatric mobile health app to a medication management system for seniors. Her sweet spot is market discovery: working with customers to understand their needs, problem solving to determine how the product may play a role to meet them, then developing and initiating pilots to measure ROI. She leads sales, often managing communications and marketing and contributing to product development as well. Cathy began her career as an MIT Chemical Engineer, then worked in pharma before following her passion and creativity to the world of startups. She prides herself on scientific expertise as well as relationship building.

Dean Papadopoulos

Dean Papadopoulos was a founder and Chief Executive Officer of Bay Bridge Decision Technologies.  Startring in 2000, Bay Bridge developed, sold, and supported CenterBridge, a contact center strategic planning, budgeting, and analysis software solution for Fortune 100 enterprises.  Bay Bridge was acquired by Interactive Intelligence in 2012. Before founding Bay Bridge, Dean served as Managing Director, Marketing and Analysis at Partners First. Prior to its sale to Wachovia Bank, Partners First was the 20th largest Visa and MasterCard issuer in the U.S.  At Partners First, Dean was responsible for all customer marketing, acquisition, and management activities; as well as customer financial and behavioral analysis, operations research, predictive modeling, CRM systems, and web-based marketing and customer servicing.Before joining Partners First, Dean was a Principal at First Annapolis Consulting, Inc., where his industry practice areas included bankcard issuing (particularly card marketing, marketing information systems, and the financial evaluation of technology investments), merchant acquiring, mortgage banking, and ATMs. He also specialized in the functional areas of business valuation, information systems, and operational re-engineering.  Prior to First Annapolis, Dean served as Chief Operating Officer and Director of First Bank, in Houston, Texas, as a management consultant at Strategic Planning Associates in Washington, DC, and as a member of the founding team of Capital One Bank.

Dean received his M.B.A. from the Harvard Business School and an M.Sc. in Economics from the London School of Economics.  He received his B.A. in Economics, magna cum laude, from Williams College.

Elizabeth Cho-Fertikh, PhD

Elizabeth Cho-Fertikh, PhD is Founder of ECF Biosolutions,, a life science consulting firm that assists emerging companies navigate the commercialization path for their therapeutic or medical device technologies from the pre-clinical to clinical stages and exit opportunities.  Identification of best-fit capital sources, both dilutive and non-dilutive, regulatory considerations, strategic partners and due diligence of the competitive landscape are further provided to support ventures.  Dr. Cho-Fertikh has over 20 years biomedical research experience in cancer biology & therapeutics involving epigenetic & immune deregulation, which has resulted in numerous high impact publications (Nature, Nature Cell Bio, PNAS).  Her background is further rooted in a decade of grants administration which encompassed technology & therapeutic development portfolios.  She is a member of the Keiretsu Angel Investor-Mid Atlantic Chapter, DC-CAAG angel investor group, and serves on the Advisory Board of the Johns Hopkins Alliance of Science & Technology, a group which evaluates the commercial viability of technologies developed at Hopkins.  Dr. Cho-Fertikh obtained her BA from Johns Hopkins University, her MA from Georgetown University, her PhD from Thomas Jefferson University, and completed her postdoctoral fellowhship at NIH/NIAMS and Harvard Medical School. She currently serves as the CEO of Carillon Biopharma, Inc, a cancer therapeutic start-up company engineering nanoparticles targeting immunosuppressive, tumor-promoting cells for elimination or reprogramming.

Alexander Antoniou, MD, MBA, MA

Alexander Antoniou is a physician and programmer working in the intersection of health and technology. An MD/MBA/MA Economics, Dr. Antoniou has spent the last decade in the hospital setting witnessing firsthand where inefficiencies persist and opportunities exist. He has completed a Nuclear Medicine Residency and Clinical Informatics fellowship at Johns Hopkins followed by several startup projects both as a co-founder and mentor. He is currently building a startup in the biometric space.

Monica Lopez-Gonzalez, PhD

Monica Lopez-Gonzalez, PhD, is Co-Founder and Scientific & Artistic Director of La Petite Noiseuse Productions,, a company at the forefront of Science-Art integration. Dr. Lopez-Gonzalez is an entrepreneur who integrates her multidisciplinary Science-Art background to develop the next generation of radically novel interdisciplinary artistic works and public engagement programs within Film, Theatre, and Photography. She uses her Cognitive Science experience to purse the company’s unique R&D program in the Neuroscience of Creativity. The company publishes all its novel works in multiple languages. Dr. Lopez-Gonzalez's expertise includes product development; operations; fundraising; digital design content and marketing; advertising; writing, editing and publishing; human resources; and intellectual property. Company products include public events such as theatrical productions, film festivals, workshops, and scientific and literary publications of all its public productions. La Petite Noiseuse Productions' work has been presented at venues including the National Academy of Sciences, DARPA, Rochester Institute of Technology, Ignite Baltimore, StarTalk TV for National Geographic Channel, the International Conference on Human Vision and Electronic Imaging, and at the International Conference on Mobile Brain-Body Imaging and the Neuroscience of Art, Innovation, and Creativity. Dr. Lopez-Gonzalez received her BAs in Psychology and French, her MA and PhD in Cognitive Science, all from Johns Hopkins University, and completed her postdoctoral fellowship in the Department of Otolaryngology: Head and Neck Surgery at Johns Hopkins School of Medicine.